• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Dr Bernard Pécoul, Founder of DNDi, receives Prince Mahidol Award and strengthens partnerships in Thailand

Home > News

Dr Bernard Pécoul, Founder of DNDi, receives Prince Mahidol Award and strengthens partnerships in Thailand

Dr. Bernard Pécoul receiving the Prince Mahidol Award from Her Royal Highness Princess Maha Chakri Sirindhorn at the Grand Palace, Thailand
31 Jan 2022
  • English
    • English
    • ไทย

In 2020, the Prince Mahidol Award Foundation in Thailand awarded the Prince Mahidol Award to DNDi’s Founder and Executive Director, Dr Bernard Pécoul, in recognition of his lifelong work in public health and his contribution in furthering research for neglected diseases.

Due to the COVID-19 pandemic, the awards ceremony was postponed. Finally on 27 January 2022, Dr Bernard Pécoul attended the official awards presentation ceremony at the Chakri Throne Hall, Grand Palace, Thailand, in the presence of Her Royal Highness Princess Maha Chakri Sirindhorn.

Dr Bernard Pécoul receiving the Prince Mahidol Award from Her Royal Highness Princess Maha Chakri Sirindhorn at the Grand Palace, Thailand

Joining Dr Pécoul were four other laureates receiving the Prince Mahidol Award prize in the field of medicine for the year 2020 and 2021: Prof. Dr Valentin Fuster, Prof. Pieter R. Cullis, Assoc. Prof. Katalin Kariko, and Prof. Drew Weissman.

The 2020 and 2021 Prince Mahidol Award laureates standing together after receiving their awards at the Grand Palace, Thailand

Dr Pécoul has generously donated his Prince Mahidol Award prize money to DNDi.

‘DNDi brings the best science to the most neglected. We research and develop safe, effective, and affordable treatments for diseases affecting many of the world’s neglected communities. We don’t do it for profit. We do it because we believe all patients have the right to the best that science has to offer, no matter where they live,’ Dr Pécoul explains.

The Prince Mahidol Award holds a special significance for Dr Pécoul since he began his career in Thailand 35 years ago, where he carried out field missions working in refugee camps for Médecins Sans Frontières (MSF) in Africa, Latin America, and Asia. It was there that he witnessed first-hand the medical neglect that eventually led him and many partners to create DNDi.

As part of his visit to Thailand, Dr Pécoul also attended several events to build local partnerships and share his expertise. Notably, DNDi and the prestigious Siriraj Hospital, Mahidol University, Thailand signed a Memorandum of Understanding to launch a new global collaboration that aims to develop a safe, affordable, and effective treatment for dengue. Dengue, a climate-sensitive neglected tropical disease, is one of the top ten threats to global public health worldwide.

The visit finished on an eye-catching note as the Navamindrapobitr 84th Anniversary Building at Siriraj Hospital joined lit up in purple and orange in recognition of World Neglected Tropical Diseases Day, which is marked on 30 January each year.

View of the Navamindrapobitr 84th Anniversary Building at Siriraj Hospital illuminated at the riverside for the World Neglected Tropical Diseases Day light-up campaign
View of the Navamindrapobitr 84th Anniversary Building at Siriraj Hospital illuminated at the riverside for the World Neglected Tropical Diseases Day light-up campaign

Event & presentation videos

  • Prince Mahidol Award ceremony
  • Prince Mahidol Award special laureates academic session – ‘From Medical Innovation to Access to Treatment for all: How endemic countries can lead efforts to ensure access for patients in the Global South’
  • Prince Mahidol Award honourary lecture – ‘Modern medicine: a triumph of science, but a defeat for access?’
  • DNDi South-East Asia Strategic Plan launch webinar – ‘South-South leadership: working together on medical R&D to meet the needs of all patients, the example of dengue’
Thailand Asia

Read, watch, share

Loading...
Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

Marco Krieger
News
30 Apr 2025

Message on the passing of Dr Marco Aurélio Krieger, Vice-President of Production and Innovation in Health, Fiocruz

Screening activities in village in Guinea
News
25 Apr 2025

Statements from Dr Luis Pizarro and Daisuke Imoto about the Hideyo Noguchi Africa Prize awarded to DNDi

Two man outside of a hospital talking with a nurse
Press releases
24 Apr 2025

Liverpool clinical trial aims to advance life-changing treatment for a deadly parasitic disease

Woman walking in a laboratory
Press releases
23 Apr 2025

DNDi welcomes GHIT support for new project with three Japanese universities to find drug candidates for Chagas disease

Stories
16 Apr 2025

Drug discovery explained: Chagas – How to prove treatments work?

Statements
16 Apr 2025

Statement from the Drugs for Neglected Diseases initiative (DNDi) on the conclusion of WHO Pandemic Agreement negotiations

Press releases
15 Apr 2025

New treatment for cryptococcal meningitis enters Phase II trial as global HIV funding cuts threaten to cause a massive increase in advanced HIV disease

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License